Clinical TrialsSearch results
Number of results: 616
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Not yet recruiting
- Phase I Single-Administration Study of TRG035 in Healthy Adults
- congenital anodontia
- Nakajima Takako
- 2024-10-08
Not yet recruiting
- Phase 1/1b study to evaluate the safety of OZTx-410 in individuals with type 1 diabetes eligible for pancreatic islet transplantation
- Type 1 Diabetes
- Yabe Daisuke
- 2024-10-03
Recruiting
- blood mitochondrial components and esophageal cancer surgery
- esophagus cancer
- Amaya Fumimasa
- 2024-10-03
Recruiting
- Multicenter collaborative study on the comprehensive collection and utilization of in-hospital real-world data (RWD) on cancer care.
- Cancer
- Muto Manabu
- 2024-09-26
Recruiting
- Phase II Clinical Trial of Preoperative Chemoradiotherapy for Resectable Pancreatic Cancer
- Pancreatic cancer
- Hatano Etsuro
- 2024-09-04
Recruiting
- A Phase I, Multicentre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending Doses of AZD1390 in Combination With Radiation Therapy in Patients With Glioblastoma Multiforme and Brain Metastases From Solid Tumors.
- Recurrent Glioblastoma Multiforme
- Hibi Kazushige
- 2024-09-02
Recruiting
- Feasibility clinical study of dynamic tumor tracking VMAT and Dynamic SwingArc VMAT for primary or metastatic pulmonary or hepatic cancers, or primary pancreatic cancer.
- Primary or metastatic pulmonary or hepatic cancers, or primary pancreatic cancer
- Mizowaki Takashi
- 2024-08-21
Not yet recruiting
- A Study of Branched Chain Amino Acid Intake in Diabetes Mellitus
- Diabetes Melitus
- Fukui Michiaki
- 2024-08-07
Recruiting
- Evaluating the Effectiveness of Sensory Room Interventions in Healthy Adults
- Healthy adults, Mental Disorders, Calming, relaxation, sensory modulation
- Inadomi Hiroyuki
- 2024-08-06
Recruiting
- Exploring the Safety and Effectiveness of Combined Azacitidine and Ruxolitinib Therapy for Acute Erythroid Leukemia
- AML with erythroid predominance or genomic abnormalities associated with activatd JAK-STAT signaling
- Kanda Junya
- 2024-07-17